Conditions: Renal Insufficiency, Chronic
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 19
Healthy volunteers: no

Brief summary:
The study to be conducted is a prospective, open label trial. It is designed to evaluate the pharmacokinetic/pharmacodynamic and coagulation parameters and safety of dabigatran etexilate in patients with chronic kidney disease.

Detailed description:

Arms:
arm 1: patient to receive a capsule containing 75 mg of dabigatran etexilate

Interventions: intervention 1: Dabigatran Etexilate
Intervention descriptions: intervention 1: Dabigatran Etexilate 75mg twice daily

Protocol document: